Back to Search
Start Over
Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data
- Source :
- Blood Advances; November 2024, Vol. 8 Issue: 21 p5641-5649, 9p
- Publication Year :
- 2024
-
Abstract
- •In patients treated with deferiprone, ANC levels <0.2 × 109/L conferred the highest risk of serious infections.•An ANC of <0.2 × 109/L may be a clinically relevant threshold to define agranulocytosis with a high risk of infection.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 8
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs66137694
- Full Text :
- https://doi.org/10.1182/bloodadvances.2023012316